On March 12, 2026, NervGen Pharma Corp. announced its voluntary delisting from the TSX Venture Exchange effective March 16, 2026, while continuing to trade on Nasdaq under the symbol 'NGEN.' This is a significant event for the company as it restructures its trading platform.